Dexacort Phosphate in Turbinaire Side Effects
Generic name: dexamethasone nasal
Note: This document contains side effect information about dexamethasone nasal. Some dosage forms listed on this page may not apply to the brand name Dexacort Phosphate in Turbinaire.
Applies to dexamethasone nasal: nasal aerosol with adapter.
Endocrine
Potential systemic endocrine side effects of intranasal use of dexamethasone include decreased carbohydrate intolerance, increased requirements for insulin or oral hypoglycemic in diabetic patients, menstrual irregularities, and hirsutism.[Ref]
Endocrine abnormalities rarely include suppression of the hypothalamic-pituitary-adrenal axis. The risk of adrenal suppression is less than that associated with systemic corticosteroids and should only be of concern with use of higher than recommended doses or with prolonged therapy.[Ref]
Local
Intranasal dexamethasone may cause local irritation including burning, dryness, and soreness. Nose bleed and sore throat have been reported. Nasal septal perforation has also been reported rarely.[Ref]
Nervous system
Nervous system adverse effects include headache and dizziness in patients treated with intranasal dexamethasone.[Ref]
Gastrointestinal
Gastrointestinal side effects include nausea, vomiting, and dry mouth. Pharyngeal candidiasis has also been reported.[Ref]
Systemic side effects are less likely to occur with the nasal use as compared to oral or parenteral administration of dexamethasone. Potential gastrointestinal adverse reactions from absorption of dexamethasone from the nasal mucosa include peptic ulcer, hemorrhage, perforation of the small and large bowel, pancreatitis, abdominal distention, and ulcerative esophagitis.[Ref]
Ocular
Ocular adverse effects are more commonly seen with systemic administration of corticosteroids. However, posterior capsular cataracts have been occasionally reported with inhaled corticosteroids, especially with long-term use. Ocular hypertension and open-angle glaucoma have also been reported.[Ref]
Immunologic
In 1993, the American Academy of Allergy and Immunology (AAAI) requested that the FDA review its decision regarding the labeled risks of the use of inhaled corticosteroids during severe viral infections. The AAAI's request was based on the lack of data linking inhaled corticosteroids to increases in complications of viral infections.[Ref]
The danger of infections from immune suppression associated with inhaled corticosteroids has been debated. No conclusive evidence is available to support an increase in tuberculosis or viral infections in patients receiving nasal dexamethasone.[Ref]
Metabolic
Metabolic side effects are generally seen only with large doses used for a prolonged time period. Salt and water retention with a corresponding rise in blood pressure, and increased potassium and calcium excretion have been reported.[Ref]
Salt restriction and potassium supplementation may be necessary to correct electrolyte imbalances.[Ref]
More about Dexacort Phosphate in Turbinaire (dexamethasone nasal)
References
1. Product Information. Dexacort Phosphate in Turbinaire (dexamethasone nasal). Medeva Pharmaceuticals. 2001;PROD.
2. Garbe E, LeLorier J, Boivin JF, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997;277:722-7.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
